The amperometric response, measured in commercial serum and serum samples from patients with colon cancer at 150 mV, was p53-specific autoantibodies concentration-dependent in a range from 0.02 to 14 U mL−1, with an LOD of 0.02 U mL−1. Here, TP53 is linked to colonic neoplasm.